Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 4
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
Online download statistics by month:
Online download statistics by month: April 2024 to January 2026
Abstract
Full
Pdf
Apr 2024
759
763
228
May 2024
281
284
142
Jun 2024
544
544
148
Jul 2024
174
174
82
Aug 2024
182
183
71
Sep 2024
143
143
47
Oct 2024
117
117
44
Nov 2024
126
126
47
Dec 2024
181
191
47
Jan 2025
135
137
60
Feb 2025
103
103
39
Mar 2025
86
86
56
Apr 2025
108
109
48
May 2025
82
84
63
Jun 2025
86
88
68
Jul 2025
1
1
0
Aug 2025
1
1
0
Sep 2025
6
6
0
Jan 2026
1
1
0
Total
3116
3141
1190
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?